Observations sous Cour eur. D.H., gde ch., 12 février 2008, Guja c. Moldavie, req. n° 14277/04

Autor: Lachapelle, Amelie

Publikováno v: Lachapelle, A 2020, Observations sous Cour eur. D.H., gde ch., 12 février 2008, Guja c. Moldavie, req. n° 14277/04 . Dans F Stévenart Meeûs & E Traversa (eds), Les grands arrêts de la jurisprudence fiscale : principes généraux . Grands arrêts, Larcier, p. 287-295 . < http://www.crid.be/pdf/crid5978-/8626.pdf >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4291::b5e6e898b76c2ba678d47aa71a115232
https://pure.unamur.be/ws/files/51712107/8626.pdf

Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) According to Baseline HbA1c and BMI.

Autor: Kis JT; Department of Internal Medicine Centrum, Szent János Hospital, Budapest, Hungary., Seufert J; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center, University of Freiburg, Freiburg, Germany., Haluzík M; Diabetes Centre, Institute for Clinical and Experimental Medicine and Charles University, Prague, Czech Republic., Bonnemaire M; General Medicines, Sanofi, Paris, France. mireille.bonnemaire@sanofi.com., Vera C; Ividata Life Sciences, Levallois-Perret, France., Tournay M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Freemantle N; Institute of Clinical Trials and Methodology, University College London, London, UK., Guja C; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Publikováno v: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Nov; Vol. 15 (11), pp. 2337-2350. Date of Electronic Publication: 2024 Sep 14.

Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group.

Autor: Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia. andrej.janez@kclj.si., Muzurovic E; Department of Internal Medicine, Endocrinology Section, Clinical Centre of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro., Bogdanski P; Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, University of Medical Sciences, Poznan, Poland., Czupryniak L; Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warszawa, Poland., Fabryova L; MetabolKLINIK sro, Department for Diabetes and Metabolic Disorders, Lipid Clinic, MED PED Centre, Biomedical Research Centre of Slovak Academy of Sciences, Slovak Health University, Bratislava, Slovak Republic., Fras Z; Preventive Cardiology Unit, Division of Medicine, University Medical Centre Ljubljana and Chair of Internal Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia., Guja C; Clinic of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania., Haluzik M; Diabetes Centre, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21, Prague 4, Czech Republic., Kempler P; Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary., Lalic N; Faculty of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia., Mullerova D; Faculty of Medicine in Pilsen, Department of Public Health and Preventive Medicine and Faculty Hospital in Pilsen, 1st Internal Clinic, Charles University, Pilsen, Czech Republic., Stoian AP; Diabetes, Nutrition and Metabolic Diseases Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Papanas N; Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece., Rahelic D; Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia.; Catholic University of Croatia School of Medicine, Zagreb, Croatia.; Josip Juraj Strossmayer, University of Osijek School of Medicine, Osijek, Croatia., Silva-Nunes J; NOVA Medical School, New University of Lisbon, Lisbon, Portugal.; Department of Endocrinology, Diabetes and Metabolism, Unidade Local de Saúde São José, Lisbon, Portugal., Tankova T; Department of Endocrinology, Faculty of Medicine, Medical University, Sofia, Bulgaria., Yumuk V; Division of Endocrinology, Metabolism and Diabetes, Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Istanbul, Turkey., Rizzo M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, Palermo, Italy.

Publikováno v: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Sep; Vol. 15 (9), pp. 1865-1892. Date of Electronic Publication: 2024 Jul 11.

Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review.

Autor: Mindrescu NM; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania., Guja C; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; National Institute of Diabetes, Nutrition and Metabolic Diseases 'NC Paulescu', 030167 Bucharest, Romania., Jinga V; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Clinical Hospital, 'Prof. Dr. Th. Burghele', 061344 Bucharest, Romania., Ispas S; Department of Anatomy, Faculty of General Medicine, 'Ovidius' University, 900470 Constanta, Romania., Curici A; Department of Cellular and Molecular Biology, and Histology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania., Nelson Twakor A; Department of Internal Medicine, Emergency County Hospital, 900591 Constanta, Romania., Pantea Stoian AM; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Internal Medicine, Emergency County Hospital, 900591 Constanta, Romania.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 21; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 21.

iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.

Autor: Guja C; Department of Diabetes, Nutrition and Metabolic Disease, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Kis JT; Department of Internal Medicine Centrum, Szent János Hospital, Budapest, Hungary., Haluzík M; Institute for Clinical and Experimental Medicine and Charles University, Prague, Czech Republic., Bonnemaire M; General Medicines, Sanofi, Paris, France., Bigot G; IVIDATA, Paris, France., Tournay M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Freemantle N; Institute of Clinical Trials and Methodology, University College London, London, UK., Seufert J; Division of Endocrinology and Diabetology, Department of Internal Medicine II, Medical Centre - Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Jun; Vol. 25 (6), pp. 1723-1730. Date of Electronic Publication: 2023 Mar 21.